Welcome to our dedicated page for MSP Recovery SEC filings (Ticker: MSPR), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The MSP Recovery, Inc. (MSPR) SEC filings page brings together the company’s official disclosures to the U.S. Securities and Exchange Commission, offering insight into its reimbursement recovery business, technology initiatives, capital structure, and listing status. MSP Recovery describes itself as a Medicare, Medicaid, commercial, and secondary payer reimbursement recovery and technology leader, and its filings expand on how this model operates in practice.
Through annual reports on Form 10‑K and quarterly reports on Form 10‑Q, MSP Recovery provides detailed information on its portfolio of assigned healthcare claims, legal strategies under the Medicare Secondary Payer Act and other laws, technology platforms such as LifeWallet and LifeChain, and risk factors related to liquidity, litigation, and regulatory matters. These periodic reports also discuss non‑GAAP measures, impairment assessments of definite‑lived intangible assets, and management’s views on going‑concern considerations.
Current reports on Form 8‑K document material events affecting the company. Recent 8‑Ks describe strategic term sheets with investors such as Hazel Partners and Virage Capital Management, bridge funding and working‑capital facilities, debt‑to‑equity conversions, and amendments to agreements with YA II PN, Ltd. (Yorkville) under a Standby Equity Purchase Agreement and related convertible promissory notes. Other 8‑Ks address reverse stock splits implemented to address Nasdaq’s minimum bid‑price rule, confidential settlements with insurers and pharmaceutical defendants, and the settlement of litigation with counterparties such as Cano Health.
Filings under Item 3.01 of Form 8‑K and related disclosures outline Nasdaq listing‑compliance issues, including deficiencies in minimum stockholders’ equity and bid‑price requirements, the company’s submission of a compliance plan, and the subsequent Nasdaq Hearings Panel decision to delist MSP Recovery’s common stock from the Nasdaq Capital Market. The company reports that it expects its common stock to trade on the OTC Markets OTCQB market under the ticker MSPR following suspension from Nasdaq, which is an important consideration for investors tracking trading venues.
Notifications of late filing on Form 12b‑25 (NT 10‑Q) provide context when MSP Recovery is unable to file a quarterly report by the prescribed deadline, such as delays related to a transition to a new independent registered public accounting firm. These notices explain the reasons for the delay and whether the company expects to file within the permitted extension period.
On this page, users can review MSP Recovery’s 10‑K and 10‑Q reports, 8‑K current reports, and other SEC submissions, while AI‑powered tools summarize key sections, highlight significant changes, and call out items such as liquidity discussions, debt and equity arrangements, reverse stock splits, and listing‑status disclosures. This helps readers quickly understand how MSP Recovery’s legal, technological, and financial developments are reflected in its official regulatory record.
MSP Recovery, Inc. files a prospectus supplement registering up to 32,220 shares of Class A common stock for resale by selling securityholders, including up to 15,239 shares issuable upon exercise of a CPIA Warrant.
The supplement attaches a Form 8-K describing two one-time advances of
MSP Recovery, Inc. amends its prospectus to register up to 909,982 shares of Class A Common Stock, up to 755,200,000 New Warrants, and up to 236,019 shares issuable upon warrant exercises, for resale by selling securityholders.
The supplement discloses that Public Warrants (exercise price
MSP Recovery, Inc. files a prospectus supplement to register 56,896 shares of Class A common stock for resale by selling securityholders, including warrants and shares issued to Virage entities and Palantir, adjusted for a 1-for-7 reverse split.
The supplement attaches a Form 8-K that discloses two short-term one-time advances: a
MSP Recovery, Inc. is registering 285,715 shares of Class A Common Stock for resale by a selling securityholder under Prospectus Supplement No. 57.
The resale registration covers shares originally issued or issuable to YA II PN, Ltd. (Yorkville) under the Standby Equity Purchase Agreement (the Yorkville SEPA). The Yorkville SEPA contemplates purchases of up to
MSP Recovery, Inc. disclosed two small, one-time funding arrangements and key leadership departures. The company obtained a $0.2 million discretionary advance from Hazel Partners Holdings LLC under its working capital credit facility and a separate $0.2 million one-time advance of recovery proceeds from VRM MSP Recovery Partners, LLC, both primarily for operating needs and accounts payable.
The company emphasizes that its Hazel facility remains fully discretionary, provides no committed liquidity, and that it has no rights to and no reasonable basis to expect further advances. It also states that the VRM advance does not imply any obligation for future funding. In addition, director Ophir Sternberg resigned from the board, and Francisco Rivas‑Vasquez resigned as Chief Financial Officer, with both departures described as not due to disagreements over operations, policies, or practices.
MSP Recovery, Inc. filed a prospectus supplement covering the resale of up to 56,896 shares of Class A common stock by selling securityholders. The shares include stock issued or issuable to Virage-affiliated entities under prior agreements and 11,180 shares issued to Palantir Technologies as compensation for products and services. Warrants tied to part of these shares have a low $0.0175 per share exercise price, so any cash the company receives from exercises would be only nominal.
Attached to the supplement, MSP Recovery reported a new letter agreement with Hazel Partners Holdings under its existing working capital credit facility. Hazel funded a one-time $250,000 advance on January 26, 2026 to be used primarily for operating expenses, increasing the Operational Collection Floor beyond its prior level. The company emphasizes this is a standalone accommodation, does not restore ongoing availability, and that it has no rights to, and no reasonable basis to expect, further advances or committed liquidity under this facility.
MSP Recovery, Inc. files a prospectus supplement covering the resale of up to 909,982 shares of Class A common stock and up to 755,200,000 warrants, plus the issuance of up to 236,019 shares upon warrant exercise. The supplement also attaches a new current report.
The report describes a $250,000 one-time advance under the discretionary Working Capital Credit Facility with Hazel Partners Holdings LLC, to be used primarily for operating expenses. The company stresses this advance is a standalone accommodation that does not reinstate or reopen availability, creates no commitment for future funding, and provides no ongoing liquidity, and states it has no reasonable basis to expect further advances under the facility.
MSP Recovery, Inc. filed a prospectus supplement registering up to 285,715 shares of Class A common stock for resale by Yorkville under an existing standby equity purchase agreement. The company will not receive proceeds from Yorkville’s resale of these shares, though it may receive cash when it elects to sell stock to Yorkville under the facility.
The attached current report also discloses a $250,000 one-time advance under MSP Recovery’s working capital credit facility with Hazel Partners Holdings. This advance is fully discretionary, does not reinstate borrowing capacity, and the company states it has no rights to and no reasonable basis to expect further funding under that facility, highlighting continued liquidity pressure alongside prior Nasdaq delisting and OTCQB trading.
MSP Recovery, Inc. has filed a prospectus supplement covering the resale, from time to time, of up to 32,220 shares of Class A Common Stock by existing holders, including 15,239 shares issuable upon exercise of a CPIA Warrant at $0.4375 per share, which would generate only nominal proceeds if exercised.
The supplement also incorporates a new agreement under which Hazel Partners Holdings LLC provided a one-time $250,000 advance under the company’s discretionary working capital credit facility, primarily for operating expenses. The company emphasizes this is a standalone accommodation, does not restore ongoing borrowing capacity, and that it has no rights to and no reasonable basis to expect further advances under the facility.
MSP Recovery, Inc. entered into a letter agreement with Hazel Partners Holdings LLC, its working capital lender, under which Hazel made a one-time discretionary advance of $250,000 on January 26, 2026, to be used primarily for operating expenses. This advance increases the amount previously drawn under the facility’s Operational Collection Floor but is described as a standalone accommodation. The company states that this funding does not reinstate or reopen availability under the working capital credit facility and that, apart from this advance, no additional funding is currently available. MSP Recovery further notes it has no rights to, and no reasonable basis to expect, any further advances, and cautions that this payment should not be seen as a sign of future support or ongoing liquidity.